Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/06/2005CA2560905A1 Conjugated psychotropic drugs and uses thereof
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560895A1 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005CA2560857A1 Tetrahydro-.beta.-carboline compounds and use thereof
10/06/2005CA2560843A1 Novel method of neuroprotection by pharmacological inhibition of amp-activated protein kinase
10/06/2005CA2560835A1 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
10/06/2005CA2560827A1 Preventing arrhythmias associated with cell transplantation
10/06/2005CA2560741A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2560696A1 Mutations of the pik3ca gene in human cancers
10/06/2005CA2560584A1 Novel compounds for modulating cell proliferation
10/06/2005CA2560538A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2560528A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2560243A1 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists
10/06/2005CA2559753A1 Bioavailable nutritional supplement and method of treatment of malabsorption
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559685A1 Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
10/06/2005CA2559532A1 Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen
10/06/2005CA2559465A1 Herbal therapy for the treatment of asthma
10/06/2005CA2559461A1 Use of metformin and orlistat for the treatment or prevention of obesity
10/06/2005CA2559266A1 Combinations comprising alpha-2-delta ligands
10/06/2005CA2559036A1 9-substituted 8-oxoadenine compound
10/06/2005CA2559029A1 Complex particles and coated complex particles
10/06/2005CA2558889A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
10/06/2005CA2558884A1 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
10/06/2005CA2558787A1 Oral matrix formulations comprising licarbazepine
10/06/2005CA2558785A1 Drug-enhanced adhesion prevention
10/06/2005CA2558598A1 Combination therapy
10/06/2005CA2558535A1 A stable pharmaceutical composition comprising an acid labile drug
10/06/2005CA2558513A1 Amorolfine patch for treating onychomycosis
10/06/2005CA2558346A1 Combination therapy
10/06/2005CA2558314A1 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
10/06/2005CA2558311A1 Novel use of peptide compounds for treating pain in painful diabetic neuropathy
10/06/2005CA2558307A1 Disintegrating tablets comprising licarbazepine
10/06/2005CA2558067A1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
10/06/2005CA2557801A1 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
10/06/2005CA2557785A1 Hiv integrase inhibitors
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005CA2557439A1 Orthoester-protected polyols for low voc coatings
10/06/2005CA2556459A1 Extended cycle multiphasic oral contraceptive method
10/06/2005CA2554860A1 Pharmaceutical composition and method for the transdermal delivery of magnesium
10/06/2005CA2554074A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
10/06/2005CA2554073A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
10/06/2005CA2554041A1 Process for the preparation of 3-amino-8-(1-piperazinyl) -2h-1-benzopyran-2-one and salts and hydrates thereof
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/06/2005CA2520166A1 A protectant of periodontal membranes
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582520A1 Novel parp inhibitors
10/05/2005EP1582517A1 Blood-brain barrier disruption inhibitors
10/05/2005EP1582225A2 Drug delivery device
10/05/2005EP1582223A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
10/05/2005EP1582222A1 Surface-active agents in powder form for use in tablets and capsules, their process of manufacture and compositions containing them
10/05/2005EP1582220A1 Composition for topical anesthesia
10/05/2005EP1582219A1 Connexin 26 inhibitors and cancer metastasis inhibitors
10/05/2005EP1582214A2 Use of chondroitin mono- and disulphates in therapy
10/05/2005EP1582213A1 Use of adenosine for treating surgery related ischemia
10/05/2005EP1582212A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages
10/05/2005EP1582211A1 Jnk inhibitor
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1582209A1 The use of succinate derivative esters for the treatment of dementia
10/05/2005EP1582208A2 An amino acid compositions for promoting collagen synthesis
10/05/2005EP1582207A1 Inhibitor for liver cancer onset and progress
10/05/2005EP1582206A1 Water-soluble composition containing coenzyme q10
10/05/2005EP1582204A2 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
10/05/2005EP1582102A1 Foods and drinks having health benefits
10/05/2005EP1581795A2 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenete trahydrofolate reductase as antibiotics
10/05/2005EP1581653A2 Targeted double stranded rna mediated cell killing
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581547A2 Compounds resistant to metabolic deactivation and methods of use
10/05/2005EP1581546A1 Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4''- or 4'-position
10/05/2005EP1581545A1 Novel anticonvulsant derivative salts
10/05/2005EP1581543A2 Methods of producing c-aryl glucoside sglt2 inhibitors
10/05/2005EP1581539A2 Novel tyrosine kinase inhibitors
10/05/2005EP1581538A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
10/05/2005EP1581534A2 Tumour-inhibiting annellated azepinone derivatives
10/05/2005EP1581533A2 Novel benzonaphthyridines
10/05/2005EP1581532A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
10/05/2005EP1581529A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks
10/05/2005EP1581528A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581526A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
10/05/2005EP1581523A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/05/2005EP1581522A1 Flavaxate derivatives as muscarinic receptor antagonists
10/05/2005EP1581520A1 Compounds, compositions and methods
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581510A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
10/05/2005EP1581509A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
10/05/2005EP1581506A1 Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents
10/05/2005EP1581500A2 Antibiotics containing borinic acid complexes and methods of use
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581487A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/05/2005EP1581484A1 Hydroxamic acid derivatives having anti-inflammatory action
10/05/2005EP1581480A1 Cyclopentil-substituted glutaramide compounds as endopeptidasev inhibitors
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
1 ... 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 4537 ... 7860